menu
    • menu

    Company profile for Pfenex

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical stage development and licensing biotechnology company focused on leveraging our Pfenex Expression Technology™ platform to develop and improve protein therapies for unmet patient needs. Through the use of our state of the art production platform, Pfenex Expression Technology®, we cost-effectively develop and improve high value protein based therapeutics and vaccines, enabling broad access to people who req...
    We are a clinical stage development and licensing biotechnology company focused on leveraging our Pfenex Expression Technology™ platform to develop and improve protein therapies for unmet patient needs. Through the use of our state of the art production platform, Pfenex Expression Technology®, we cost-effectively develop and improve high value protein based therapeutics and vaccines, enabling broad access to people who require them. Pfenex Inc. existed as a privately held biotechnology company from 2009 until our initial public offering in 2015.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PfenexUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Pfenex Inc. 10790 Roselle St. San Diego, CA 92121
    Telephone
    Telephone
    (858)352-4400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pfenex.com
    Linkedin
    Linkedin
    https://www.linkedin.com/company/pfenex-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/pfenex

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LIGAND COMPLETES ACQUISITION OF PFENEX INC.
    LIGAND COMPLETES ACQUISITION OF PFENEX INC.

    01 Oct 2020

    // PRESS RELEASE

    https://investor.ligand.com/press-releases/detail/428/ligand-completes-acquisition-of-pfenex-inc

    PRESS RELEASE
    01 Oct 2020
    Share Share
    Ligand Completes Acquisition of Pfenex Inc.
    Ligand Completes Acquisition of Pfenex Inc.

    01 Oct 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20201001005654/en

    BUSINESSWIRE
    01 Oct 2020
    Share Share
    Ligand to Acquire Pfenex Inc.
    Ligand to Acquire Pfenex Inc.

    10 Aug 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200810005790/en/Ligand-Acquire-Pfenex#:~:text=SAN%20DIEGO%2D%2D(BUSINESS%20WIRE,on%20a%20fully%20diluted%20basis.

    BUSINESSWIRE
    10 Aug 2020
    Share Share
    Pfenex Announces Positive European CHMP Opinion for PF708
    Pfenex Announces Positive European CHMP Opinion for PF708

    26 Jun 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/06/26/2054222/0/en/Pfenex-Announces-Positive-European-CHMP-Opinion-for-PF708-EU-Brand-Name-Livogiva-and-New-Partnership-in-Latin-America-and-Provides-CRM197-Business-Update.html

    GLOBENEWSWIRE
    26 Jun 2020
    Share Share
    Pfenex Announces FDA Requests Additional Comparative Use Human Factors Data
    Pfenex Announces FDA Requests Additional Comparative Use Human Factors Data

    15 Apr 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/04/14/2016034/0/en/Pfenex-Announces-FDA-Requests-Additional-Comparative-Use-Human-Factors-Data-in-Experienced-Users-in-order-to-Complete-PF708-Therapeutic-Equivalence-Determination.html

    GLOBENEWSWIRE
    15 Apr 2020
    Share Share
    Pfenex Earns $15M Jazz Milestone
    Pfenex Earns $15M Jazz Milestone

    18 Dec 2019

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2019-12-18/pfenex-earns-15m-jazz-milestone/

    CONTRACT PHARMA
    18 Dec 2019
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search